Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,986 | 19,267 | 80,642 | 13,141 | 13,856 |
| Marketable Securities | 68,685 | 60,728 | 13,384 | 21,048 | 4,512 |
| Receivables | N/A | N/A | N/A | 341 | 112 |
| Other current assets | 2,233 | 2,432 | 1,463 | 1,301 | 2,364 |
| TOTAL | $85,600 | $92,496 | $102,784 | $39,857 | $24,089 |
| Non-Current Assets | |||||
| PPE Net | 7,655 | 8,401 | 9,148 | 9,955 | 10,965 |
| Intangibles | 4,671 | 4,671 | 4,671 | 4,671 | 4,671 |
| Other Non-Current Assets | 2,413 | 2,922 | 3,122 | 3,326 | 4,103 |
| TOTAL | $14,739 | $15,994 | $16,941 | $17,952 | $19,739 |
| Total Assets | $100,339 | $108,490 | $119,725 | $57,809 | $43,828 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,750 | 11,000 |
| Accounts payable and accrued liabilities | 3,661 | 2,779 | 1,961 | 2,110 | 2,390 |
| Accrued Expenses | 2,426 | 12,323 | 2,467 | 2,419 | 371 |
| Other current liabilities | 10,415 | 676 | 11,668 | 218 | 9,014 |
| TOTAL | $31,937 | $27,548 | $26,697 | $14,085 | $30,839 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,729 | 13,017 | 13,704 | 14,392 | 6,600 |
| Deferred Revenues | 8,737 | 7,357 | 5,977 | 4,597 | 5,955 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 5,552 | 0 |
| TOTAL | $9,886 | $13,368 | $14,378 | $21,023 | $8,104 |
| Total Liabilities | $41,823 | $40,916 | $41,075 | $35,108 | $38,943 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,215 | 31,944 | 31,860 | 26,020 | 76,168 |
| Common Shares | 32 | 32 | 32 | 26 | 65 |
| Retained earnings | -243,066 | -232,197 | -221,237 | -203,559 | -194,169 |
| Other shareholders' equity | -79 | -307 | -5 | -45 | -15 |
| TOTAL | $58,516 | $67,574 | $78,650 | $22,701 | $4,885 |
| Total Liabilities And Equity | $100,339 | $108,490 | $119,725 | $57,809 | $43,828 |